The anti-Candida vaccine based on the recombinant N-terminal domain of Als1p is broadly active against disseminated candidiasis.
Ibrahim AS, Spellberg BJ, Avanesian V, Fu Y, Edwards JE Jr.
Ibrahim AS, et al. Among authors: fu y.
Infect Immun. 2006 May;74(5):3039-41. doi: 10.1128/IAI.74.5.3039-3041.2006.
Infect Immun. 2006.
PMID: 16622247
Free PMC article.
Ibrahim, B. J. Spellberg, V. Avenissian, Y. Fu, S. G. Filler, and J. E. Edwards, Jr., Infect. Immun. 73:999-1005, 2005, and B. ...Ibrahim, V. Avenissian, S. G. Filler, C. Myers, Y. Fu, and J. E. Edwards, Jr., Infect. Immun. 73:6191-6193, 2005). Here we …
Ibrahim, B. J. Spellberg, V. Avenissian, Y. Fu, S. G. Filler, and J. E. Edwards, Jr., Infect. Immun. 73:999-1005, 2005, and B. …